CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-15 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 268,554 |
| 2022-09-15 | Patel Sanjiv President and CEO | Sale | −14,000 | $23.80 | $333K | 254,554 |
| 2022-09-15 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 74,175 | ||
| 2022-09-14 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 268,554 |
| 2022-09-14 | Patel Sanjiv President and CEO | Sale | −14,000 | $23.47 | $329K | 254,554 |
| 2022-09-14 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 88,175 | ||
| 2022-09-13 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 268,554 |
| 2022-09-13 | Patel Sanjiv President and CEO | Sale | −14,000 | $25.45 | $356K | 254,554 |
| 2022-09-13 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 102,175 |
Page 17 of 17 · 329 trades